KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Astrana Health (ASTH) Other Operating Expenses (2016 - 2025)

Astrana Health's Other Operating Expenses history spans 15 years, with the latest figure at $373000.0 for Q3 2025.

  • For Q3 2025, Other Operating Expenses rose 104.16% year-over-year to $373000.0; the TTM value through Sep 2025 reached $1.1 billion, up 8699.9%, while the annual FY2024 figure was $20.9 million, 63.6% down from the prior year.
  • Other Operating Expenses for Q3 2025 was $373000.0 at Astrana Health, down from $583.7 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $583.7 million in Q2 2025 and bottomed at -$33.3 million in Q4 2024.
  • The 5-year median for Other Operating Expenses is $144.8 million (2021), against an average of $166.5 million.
  • The largest annual shift saw Other Operating Expenses crashed 343.86% in 2024 before it soared 5811.32% in 2025.
  • A 5-year view of Other Operating Expenses shows it stood at $176.3 million in 2021, then surged by 39.3% to $245.5 million in 2022, then tumbled by 103.05% to -$7.5 million in 2023, then plummeted by 343.86% to -$33.3 million in 2024, then soared by 101.12% to $373000.0 in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Other Operating Expenses are $373000.0 (Q3 2025), $583.7 million (Q2 2025), and $555.9 million (Q1 2025).